Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Ga Bard who wrote (636)	5/2/1998 10:50:00 PM
From: Jeffrey L. Henken	Respond to of 2887

What kind of catheters is American BioMed currently shipping to distributors? You can check out some of these products and their competitive advantages: americanbiomed.com Latex Free, State-of-the-Art Silicone Balloon Catheters 100% silicone design; health care workers and patients avoid unnecessary risk of exposure to latex or PVC. Exclusive one-piece balloon catheter increases overall product smoothness reducing vascular trauma. Shatter-proof balloon. Syringe included with each catheter for easy and convenient preparation. Unique, integrated design eliminates use of a stylet. Smaller packaging increases ease of storage. Single Lumen Embolectomy Catheters Bi-Lumen Embolectomy and Irrigation Catheters Thermodilution Catheters Occlusion and Biliary Catheters Angiographic/Angioscopic Irrigation Catheters Foley (Urological) Catheters Drug Delivery Catheters Let's not forget the recently approved Ahn Thromectomy Catheter! This one could really be a big seller. AMERICAN BIOMED RECEIVES FDA APPROVAL TO MARKET NEW, SAFER THROMBECTOMY CATHETER americanbiomed.com Regards, Jeff

To: Ga Bard who wrote (636)	5/2/1998 10:58:00 PM
From: Jeffrey L. Henken	Read Replies (2) \| Respond to of 2887

Another post from a previous question about a possible buy out of American BioMed: Message 3654021 Consolidation in the Healthcare Industry-Fact and Fantasy As a rule Bill I don't like the discussion of take over and merger activity very much at all. Too much hype too little substance. In the last year I have been invested in a number high technology companies whose names came up as acquisition targets. More often than not they are not the rumors are unfounded. Even if it is true most likely a real merger or acquisition of the company will take place when you least expect it. First let me give you a list of just a few of the stocks I have owned in the last twelve months that were rumored to be on the auction block. These stocks all got a nice pop higher on these rumors that never happened. IFMX (Informix)-I think this was supposed to be by IBM ASND (Ascend Communications)-AT&T, Lucent take your pick MUEI (Micron Electronics)-Compaq To date there has been no buy outs for these companies although the possibility certainly exists. To be fair there have been some very real buy outs in my portfolio like Cascade Communications by Ascend. But that was not a big money maker for me. Now even when something good like this does happen it usually catches you when you least expect it. This happened to me with Baxter International's buy out of of another company I owned blood substitute maker SMTG (Somatogen). fnews.yahoo.com Which at least gets us back to the healthcare industry which has indeed seen it's fair share of buyout activity. Interestingly enough Baxter invented the catheter and might be a potential suitor of American BioMed's. Johnson & Johnson might be interested since they appear to be losing stent market share to Guidant. devicelink.com Indeed even Guidant could conceivably desire American BioMed's techonology and patent portfolio. biz.yahoo.com Bottom line is most rumored mergers and acquisitions are just that only rumors. However I do believe that American BioMed is indeed a ripe acquisition target but they may never be acquired. To me it is comforting to be able to personally value ABMI at a level significantly higher than our closing price today. One final thought about the valuation of the company in the event of a buyout. Look carefully at the purchase price of the companies discussed here today in the URL's above. If ABMI was to be sold to another company it might not fetch Bill's figure of $7.50 a share but it sure won't be cheap! Go ABMI! Regards, Jeff